Literature DB >> 2816310

Disc degeneration and lumbar instability. Magnetic resonance examination of 16 patients.

H Paajanen1, M Erkintalo, S Dahlström, T Kuusela, E Svedström, M Kormano.   

Abstract

Flexion and extension radiographs of 75 young males with low back pain disclosed abnormal segmental motion of the lumbar spine in 16 patients with translational movements in 20 intervertebral segments. These 16 patients were further investigated by magnetic resonance imaging to assess disc degeneration in the unstable segments. On T2-weighted images of the 20 segments, the disc was normal in 13 and degenerated in only 7 patients. Thus, the initial factor in lumbar instability in young patients with low back pain is not always degeneration of the disc.

Entities:  

Mesh:

Year:  1989        PMID: 2816310     DOI: 10.3109/17453678909149300

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  4 in total

1.  Association of incipient disc degeneration and instability in spondylolisthesis. A magnetic resonance and flexion-extension radiographic study of 20-year-old low back pain patients.

Authors:  H Paajanen; M Tertti
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

2.  Lumbar disc degeneration and segmental instability: a comparison of magnetic resonance images and plain radiographs of patients with low back pain.

Authors:  M Murata; Y Morio; K Kuranobu
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

3.  Age-related MRI changes at 0.1 T in cervical discs in asymptomatic subjects.

Authors:  I J Lehto; M O Tertti; M E Komu; H E Paajanen; J Tuominen; M J Kormano
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

4.  Grade three disc degeneration is a critical stage for anterior spondylolisthesis in lumbar spine.

Authors:  Tetsuhiro Iguchi; Kotaro Nishida; Takuma Ozaki; Atsushi Kitagawa; Nobuhiro Tsumura; Kenichiro Kakutani; Takashi Yurube; Ryosuke Kuroda
Journal:  Eur Spine J       Date:  2012-04-10       Impact factor: 3.134

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.